The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity.
Phase of Trial: Phase I
Latest Information Update: 06 Jul 2018
At a glance
- Drugs Fluoxetine (Primary) ; Caffeine; Dextromethorphan; Lovastatin; Midazolam; Omeprazole
- Indications Depressive disorders
- Focus Pharmacokinetics
- 19 Jun 2012 Actual end date (June 2012) added as reported by ClinicalTrials.gov.
- 19 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Apr 2012 Planned end date changed from 1 Mar 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.